5-(3-Chlorophenyl)-3-(2-(2-fluorophenyl)-2-oxoethyl)pyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione

Catalog No. :
ACWHCM073
CAS No. :
1464091-51-7
Molecular Formula :
C20H13ClFN3O3
Molecular Weight :
397.79

IUPAC Name:5-(3-chlorophenyl)-3-(2-(2-fluorophenyl)-2-oxoethyl)pyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione

5-(3-Chlorophenyl)-3-(2-(2-fluorophenyl)-2-oxoethyl)pyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$524.00Login to see priceInquiryInquiry
100mg95%$2095.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(3-Chlorophenyl)-3-(2-(2-fluorophenyl)-2-oxoethyl)pyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione
IUPAC Name5-(3-chlorophenyl)-3-(2-(2-fluorophenyl)-2-oxoethyl)pyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione
MDL No.MFCD26406729
Molecular FormulaC20H13ClFN3O3
Molecular Weight397.79
SMILESO=C1NN(C(NC(C2=CC=CC(Cl)=C2)=C3)=C1CC(C4=CC=CC=C4F)=O)C3=O
InChI KeyOTYYYLHQCMBBQL-UHFFFAOYSA-N
Synonym5-(3-Chlorophenyl)-3-(2-(2-fluorophenyl)-2-oxoethyl)pyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione;Pyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione, 5-(3-chlorophenyl)-3-[2-(2-fluorophenyl)-2-oxoethyl]-
CAS No.1464091-51-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWHCM073 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHCM073 route product structure diagram
    ACWHCM0731464091-51-7
Inquiry

2. ACWHCM073 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHCM073 route product structure diagram
    ACWHCM0731464091-51-7
Inquiry

Comments (0)